Status:
NOT_YET_RECRUITING
WhatsApp-Based Education Program for Stroke Patients
Lead Sponsor:
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Conditions:
Type 2 Diabetes Mellitus (T2DM)
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Stroke is one of the leading causes of death and disability worldwide, with type 2 diabetes mellitus (T2DM) being a major risk factor that doubles the risk of ischemic stroke. Glycemic dysregulation i...
Detailed Description
Stroke remains the second leading cause of mortality and long-term disability worldwide. Type 2 diabetes mellitus (T2DM) is a well-established risk factor, doubling the risk of ischemic stroke compare...
Eligibility Criteria
Inclusion
- Adults aged 18 years and older
- Diagnosis of ischemic stroke
- Mini-Mental Test (MMT) score \> 18
- Receiving insulin therapy for type 2 diabetes mellitus (T2DM)
- Ability to use WhatsApp on a smartphone (participant or caregiver)
- Willingness to provide informed consent
Exclusion
- Presence of major organ failure
- Development of severe T2DM-related complications (e.g., diabetic foot, nephropathy, cardiovascular disease)
- Cognitive or communication impairments preventing participation
Key Trial Info
Start Date :
October 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 15 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT07207694
Start Date
October 15 2025
End Date
November 15 2026
Last Update
October 6 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.